GAMMA Investing’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
3,605
+1,382
+62% +$121K 0.01% 945
2026
Q1
$201K Sell
2,223
-164
-7% -$15K 0.01% 1107
2025
Q4
$215K Sell
2,387
-1,207
-34% -$114K 0.01% 985
2025
Q3
$354K Buy
3,594
+1,012
+39% +$100K 0.02% 637
2025
Q2
$236K Sell
2,582
-920
-26% -$89K 0.01% 809
2025
Q1
$396K Buy
3,502
+1,204
+52% +$129K 0.03% 500
2024
Q4
$243K Buy
2,298
+927
+68% +$99.5K 0.02% 610
2024
Q3
$148K Buy
1,371
+385
+39% +$42K 0.01% 765
2024
Q2
$107K Buy
986
+443
+82% +$52.2K 0.01% 742
2024
Q1
$71.7K Buy
543
+23
+4% +$2.87K 0.01% 811
2023
Q4
$65.3K Buy
+520
New +$58K 0.02% 749

Other funds holding ZBH

GAMMA Investing's ZBH Position: Q2 2026 in Review

GAMMA Investing increased its Zimmer Biomet (ZBH) stake by 62% in Q2 2026, buying an estimated $121K and bringing the position to 3,605 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #945.

GAMMA Investing first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $396K in Q1 2025. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • GAMMA Investing held 3,605 shares of Zimmer Biomet worth $310K as of Q2 2026.
  • GAMMA Investing bought 1,382 Zimmer Biomet shares in Q2 2026, an estimated $121K.
  • Zimmer Biomet made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #945 holding.
  • GAMMA Investing first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Zimmer Biomet position peaked at $396K in Q1 2025.
  • 150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.